Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Country:  U.S.A.
Trial Type:  Supportive care
Treatment/Intervention:  supportive care
Results 1-25 of 408 for your search:
Start Over
Perampanel in Lowering the Incidence of Seizures in Patients with Primary Glioma
Status: Active
Phase: Phase IV
Type: Supportive care
Age: 18 and over
Trial IDs: Pro00055609, NCI-2015-00365, NCT02363933
Gabapentin in Reducing Pain after Surgery in Patients with Head and Neck Cancer
Status: Active
Phase: Phase IV
Type: Supportive care
Age: 18 and over
Trial IDs: 201605121, NCI-2016-01048, NCT02926573
Eltrombopag Olamine in Treating Thrombocytopenia in Patients with Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy
Status: Active
Phase: Phase III, Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 2011-0319, NCI-2011-03336, NCT01428635
Atorvastatin Calcium in Preventing Cardiovascular Complications in Patients with Newly Diagnosed Stage I-III Breast Cancer or Stage I-IV Lymphoma Undergoing Anthracycline-Based Chemotherapy
Status: Active
Phase: Phase III, Phase II
Type: Supportive care
Age: 30 to 80
Trial IDs: 98213, NCI-2013-01760, 00024197, CCCWFU 98213, WF 98213, WFU 98213, NCT01988571
Fentanyl Sublingual Spray in Treating Exercise-Induced Breakthrough Dyspnea in Patients with Cancer
Status: Active
Phase: Phase III, Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 2015-0137, NCI-2015-02132, NCT02597478
Radiation Therapy with or without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Status: Active
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG-0920, NCI-2011-00878, CDR0000651536, NCT01311063, NCT00956007
Chemotherapy and Pelvic Radiation Therapy with or without Additional Chemotherapy in Treating Patients with High-Risk Early-Stage Cervical Cancer after Radical Hysterectomy
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG 0724/GOG-0724, NCI-2011-01973, CDR0000654709, GOG-0724, RTOG-0724, NCT00980954
Acupuncture in Treating Dry Mouth Caused by Radiation Therapy in Patients with Head and Neck Cancer
Status: Active
Phase: Phase III
Type: Supportive care
Age: Not specified
Trial IDs: MDA-04-01, NCI-2011-02073, CDR0000674208, WFU 97115, WF-97115, NCT01141231
Risk-Adapted Chemotherapy in Treating Younger Patients with Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
Status: Active
Phase: Phase III
Type: Supportive care, Treatment
Age: 1 to < 10
Trial IDs: AALL0932, NCI-2011-02599, CDR0000683227, COG-AALL0932, NCT01190930
Yoga or Stretching and Relaxation in Improving Physical Function in Patients with Stage 0-III Breast Cancer Undergoing Radiation Therapy
Status: Active
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: 2009-0976, NCI-2012-01895, NCT01202851
Cisplatin and Radiation Therapy with or without Carboplatin and Paclitaxel in Patients with Locally Advanced Cervical Cancer
Status: Active
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: ANZGOG-0902-GOG-0274, NCI-2011-02978, ANZGOG-0902, ANZGOG-0902/GOG-0274/RTOG-1174, CDR0000706698, GOG-0274, RTOG-1174, NCT01414608
Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Patients with Early-Stage Breast Cancer
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Age: Postmenopausal
Trial IDs: S1200, NCI-2012-00251, CDR0000725249, SWOG-S1200, NCT01535066
Testosterone in Treating Postmenopausal Patients with Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: A221102, NCI-2012-00719, CDR0000730083, CALGB-A221102, NCCTG-N10C7, NCT01573442
Duloxetine Hydrochloride in Treating Muscle, Bone, and Joint Pain in Patients With Early-Stage Breast Cancer Receiving Hormone Therapy
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Age: Not specified
Trial IDs: S1202, NCI-2012-01960, CDR0000730691, SWOG-S1202, NCT01598298
Robotic Assisted Laparoscopic Prostatectomy with or without Pelvic Drain Placement in Reducing Adverse Events after Surgery in Patients with Prostate Cancer
Status: Active
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: 11113, NCI-2012-00558, NCT01613651
Proton Beam or Intensity-Modulated Radiation Therapy in Treating Patients with Low or Low-Intermediate Risk Prostate Cancer
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: 11-497, NCI-2012-01144, NCT01617161
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Status: Active
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: 2012-PT023, NCI-2013-00997, NCT01767857
Armodafinil in Reducing Cancer-Related Fatigue in Patients with High-Grade Glioma
Status: Active
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: A221101, NCI-2012-02020, N10C3, NCT01781468
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
Status: Active
Phase: Phase III
Type: Supportive care
Age: 13 and over
Trial IDs: P06200, NCI-2013-02285, 2011-003938-14, 5592-069, NCT01782131
Bortezomib or Carfilzomib with Lenalidomide and Dexamethasone in Treating Patients with Newly Diagnosed Multiple Myeloma
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: E1A11, NCI-2012-02608, ECOG-E1A11, NCT01863550
Patient Navigation Intervention in Improving Surgery Rates in African Americans with Early Stage Non-small Cell Lung Cancer
Status: Active
Phase: Phase III
Type: Educational/Counseling/Training, Supportive care
Age: 21 and over
Trial IDs: 01414, NCI-2014-02559, 101487, WF-01414, WFU-01414, NCT01885455
Antiemetic Therapy with or without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients with Cancer Receiving Highly Emetogenic Chemotherapy
Status: Active
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: A221301, NCI-2014-00446, NCT02116530
Start Over